288 related articles for article (PubMed ID: 32735324)
41. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Mulder MT; Hirankarn N; van Hagen PM; Dik WA
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5457-64. PubMed ID: 26284551
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic Potential of Targeting Periostin in the Treatment of Graves' Orbitopathy.
Jang SY; Kim J; Park JT; Liu CY; Korn BS; Kikkawa DO; Lee EJ; Yoon JS
Front Endocrinol (Lausanne); 2022; 13():900791. PubMed ID: 35707463
[TBL] [Abstract][Full Text] [Related]
43. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
44. Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
Zhang C; Zhang X; Ma L; Peng F; Huang J; Han H
Endocrine; 2012 Apr; 41(2):248-55. PubMed ID: 22237514
[TBL] [Abstract][Full Text] [Related]
45. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
[TBL] [Abstract][Full Text] [Related]
46. Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.
Zhu R; Wang XH; Wang BW; Ouyang X; You YY; Xie HT; Zhang MC; Jiang FG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108173
[TBL] [Abstract][Full Text] [Related]
47. Dickkopf1 Up-Regulation Induced by a High Concentration of Dexamethasone Promotes Rat Tendon Stem Cells to Differentiate Into Adipocytes.
Chen W; Tang H; Liu X; Zhou M; Zhang J; Tang K
Cell Physiol Biochem; 2015; 37(5):1738-49. PubMed ID: 26544628
[TBL] [Abstract][Full Text] [Related]
48. Mechanical Stress Regulates Osteogenesis and Adipogenesis of Rat Mesenchymal Stem Cells through PI3K/Akt/GSK-3
Song F; Jiang D; Wang T; Wang Y; Lou Y; Zhang Y; Ma H; Kang Y
Biomed Res Int; 2017; 2017():6027402. PubMed ID: 28286769
[TBL] [Abstract][Full Text] [Related]
49. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
50. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
[TBL] [Abstract][Full Text] [Related]
51. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
[TBL] [Abstract][Full Text] [Related]
52. Role of binding immunoglobulin protein (BiP) in Graves' orbitopathy pathogenesis.
Ko J; Kim JY; Lee EJ; Yoon JS
J Mol Endocrinol; 2021 Jan; 66(1):71-81. PubMed ID: 33112798
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
[TBL] [Abstract][Full Text] [Related]
54. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.
Draman MS; Grennan-Jones F; Zhang L; Taylor PN; Tun TK; McDermott J; Moriarty P; Morris D; Lane C; Sreenan S; Dayan C; Ludgate M
Thyroid; 2013 Dec; 23(12):1600-8. PubMed ID: 24001049
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effect 6-gingerol on adipogenesis through activation of the Wnt/β-catenin signaling pathway in 3T3-L1 adipocytes.
Li C; Zhou L
Toxicol In Vitro; 2015 Dec; 30(1 Pt B):394-401. PubMed ID: 26498061
[TBL] [Abstract][Full Text] [Related]
56. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS
Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725
[No Abstract] [Full Text] [Related]
57. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
[TBL] [Abstract][Full Text] [Related]
58. [Experimental study on the mechanism of glycogen synthase kinase-3β inhibitor on acute kidney injury of acute necrotizing pancreatitis in rats].
Zhao K; Yang X; Chen C; Zhao L; Mei F; Hong Y; Wang W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):719-724. PubMed ID: 31315730
[TBL] [Abstract][Full Text] [Related]
59. Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy.
Yoon JS; Lee HJ; Choi SH; Chang EJ; Lee SY; Lee EJ
PLoS One; 2011; 6(10):e26261. PubMed ID: 22039452
[TBL] [Abstract][Full Text] [Related]
60. A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.
Kumar S; Schiefer R; Coenen MJ; Bahn RS
Thyroid; 2010 Jan; 20(1):59-65. PubMed ID: 20017620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]